Amgen Czech Republic made a net profit of CZK 37.8 mil in 2017, up 20.0% when compared to the last year. Total sales reached CZK 417 mil, which is down 33.4% when compared to the previous year.
Historically, the company’s net profit reached an all time high of CZK 46.2 mil in 2011 and an all time low of CZK 9.88 mil in 2007.
In terms of sales, Amgen Czech Republic reached an all time high of CZK 637 mil in 2014 and an all time low of CZK 135 mil in 2006.
Amgen Czech Republic's net profit has grown 5.94% a year on average in the last five years while sales have increased by 0.037% a year since 2012.
The firm generated its shareholders an average return on invested capital of 29.5% in the last five years.
|Amgen Czech Republic||CZK mil||46.2||28.3||28.7||40.5||35.8|
|Bayer Czech Republic||CZK mil||166||83.4||96.2||107||123|
|GlaxoSmithKline Czech Republic||CZK mil||240||164||127||87.7||125|
|Merck Czech Republic||CZK mil||49.3||63.4||27.4||34.9||68.6|
|Novartis Czech Republic||CZK mil||41.7||50.0||52.3||82.2||82.7|
|Pfizer Czech Republic||CZK mil||231||48.1||144||134||75.4|
|Roche Czech Republic||CZK mil||50.5||38.7||135||94.9||51.0||...|
|Sanofi-Aventis Czech Republic||CZK mil||55.1||45.2||65.2||1.19||58.6|
|Servier Czech Republic||CZK mil||...||...||12.8||13.6||13.6||15.9|